Literature DB >> 3610396

High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.

H K Nakazawa, S Handa, Y Nakamura, H Oyanagi, M Hasegawa, N Ishikawa, O Ozaki, K Ito.   

Abstract

We performed rhythm conversion on 33 euthyroid patients with post-thyrotoxic atrial fibrillation who do not revert spontaneously to sinus rhythm from atrial fibrillation. The duration of atrial fibrillation ranged from 9 to 59 months (mean 25 +/- 14). The protocol of rhythm conversion was to first attempt pharmacological conversion with disopyramide and then to perform electrical cardioversion on the non-converters. Of 33 patients, 25 were converted to sinus rhythm (6 by disopyramide and 19 by electrical cardioversion), resulting in 8 non-converters. However, it was later discovered that cardioversion had been applied to 4 of the 8 non-converters when these patients had had a recurrence of thyrotoxicosis. These 4 patients were subjected to a second electrical cardioversion after attaining the euthyroid state. Sinus rhythm was restored in all 4 patients, giving a cardioversion rate of 88%. The sinus rhythm was maintained in 25 of the total 29 converters (86%) at the time of follow-up (10-68 months, mean 35 +/- 19 months). Our studies suggest that cardioversion should be encouraged for thyrotoxic atrial fibrillation, even if the duration of atrial fibrillation is long-standing, since there is excellent maintenance of sinus rhythm and even delayed application of cardioversion may improve its success rate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3610396     DOI: 10.1016/0167-5273(87)90269-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Efficacy of disopyramide in conversion and prophylaxis of post-thyrotoxic atrial fibrillation.

Authors:  H Nakazawa; N Ishikawa; J Noh; T Sugimoto; M Yoshimoto; T Yashiro; O Ozaki; K Ito
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Atrial fibrillation with hyperthyroidism in a 14-year-old male.

Authors:  Hisashi Takasugi; Kota Ao; Tetsuya Sato; Akihiko Maeda; Taisuke Okada; Hiroshi Wakiguchi
Journal:  Pediatr Cardiol       Date:  2006-11-07       Impact factor: 1.655

Review 3.  Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.

Authors:  Baris Gencer; Anne R Cappola; Nicolas Rodondi; Tinh-Hai Collet
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-04       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.